Neurovations Revenue and Competitors
Estimated Revenue & Valuation
- Neurovations's estimated annual revenue is currently $3.4M per year.
- Neurovations's estimated revenue per employee is $168,000
Employee Data
- Neurovations has 20 Employees.
- Neurovations grew their employee count by -5% last year.
Neurovations's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Marketing Director | Reveal Email/Phone |
3 | Project Manager | Reveal Email/Phone |
4 | Clinical Research Coordinator | Reveal Email/Phone |
5 | Conference and Community Coordinator | Reveal Email/Phone |
6 | Lead CRC | Reveal Email/Phone |
Neurovations Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.2M | 27 | 80% | N/A | N/A |
#2 | $0.3M | 8 | -33% | N/A | N/A |
#3 | $1.7M | 68 | 106% | N/A | N/A |
#4 | $4M | 24 | 14% | $26.1M | N/A |
#5 | $1.7M | 4 | 0% | $1.7M | N/A |
#6 | $7.5M | 29 | 21% | N/A | N/A |
#7 | $3.5M | 15 | 0% | $37.9M | N/A |
#8 | $1.1M | 14 | 133% | N/A | N/A |
#9 | $1.1M | 6 | 50% | N/A | N/A |
#10 | $3.4M | 20 | -5% | N/A | N/A |
What Is Neurovations?
Napa Pain Institute was formed by Dr. Eric Grigsby in 1992 and has evolved into Neurovations, a patient care, and innovation company. Neurovations provides the best care for every patient we see- every day. Today, we are a national leader in medical device and pharmaceutical innovation, clinical research, pain, and neuroscience education, and community health through our non-profit Foundation, HealthRoots. Our unwavering mission is to inspire hope and to contribute to the health and well-being of our patients and communities through integrated clinical practice, research, and education.
keywords:N/AN/A
Total Funding
20
Number of Employees
$3.4M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15M | 20 | -9% | N/A |
#2 | $2.9M | 21 | -9% | N/A |
#3 | $2.9M | 21 | 24% | N/A |
#4 | $2.4M | 21 | N/A | N/A |
#5 | $2.1M | 21 | 11% | N/A |